Clinical Trial Update: Group Retreat Psilocybin Therapy for the Treatment of Anxiety and Depression in Patients With Metastatic Solid Tumors or Incurable Hematologic Malignancies [Phase 2]

View source ↗

Summary

Phase 2 clinical trial evaluating psilocybin therapy for anxiety and depression in patients with metastatic solid tumors or incurable hematologic malignancies; …

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Anxiety Disorder
• Major Depressive Disorder

Drugs mentioned

• Psilocybin (psilocybin)

Snippet

Sponsor: University of Washington | Conditions: Anxiety, Depression | Phase 2 | Status: RECRUITING